Identification of tumor-agnostic biomarkers for predicting prostate cancer progression and biochemical recurrence

The diverse clinical outcomes of prostate cancer have led to the development of gene signature assays predicting disease progression. Improved prostate cancer progression biomarkers are needed as current RNA biomarker tests have varying success for intermediate prostate cancer. Interest grows in uni...

Descripción completa

Detalles Bibliográficos
Autores principales: Lautert-Dutra, William, Melo, Camila M., Chaves, Luiz P., Souza, Francisco C., Crozier, Cheryl, Sundby, Adam E., Woroszchuk, Elizabeth, Saggioro, Fabiano P., Avante, Filipe S., dos Reis, Rodolfo B., Squire, Jeremy A., Bayani, Jane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641020/
https://www.ncbi.nlm.nih.gov/pubmed/37965470
http://dx.doi.org/10.3389/fonc.2023.1280943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641020/
https://www.ncbi.nlm.nih.gov/pubmed/37965470
http://dx.doi.org/10.3389/fonc.2023.1280943

Ejemplares similares